Arivarasan Karunamurthy

Arivarasan Karunamurthy

University of Pittsburgh

H-index: 15

North America-United States

About Arivarasan Karunamurthy

Arivarasan Karunamurthy, With an exceptional h-index of 15 and a recent h-index of 13 (since 2020), a distinguished researcher at University of Pittsburgh, specializes in the field of Dermatopathology, Molecular Genetic Pathology, Immunotherapeutics, Cancer Genomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy

45 An integrative immune signature of complementary circulating and tumoral biomarkers maximizes the predictive power of adjuvant immunotherapeutic benefits for high-risk melanoma

3D reconstruction of skin and spatial mapping of immune cell density, vascular distance and effects of sun exposure and aging

Hydroxychloroquine‐induced repetitive atypical pustular drug eruptions in the same patient separated by 12 years

Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes

An integrated immune signature predictive of adjuvant immunotherapeutic benefits for high-risk melanoma

Poorer survival outcomes in patients with multiple versus single primary melanoma

Improvement of Unilateral Breast Hypoplasia With Oral Spironolactone in a Patient With Becker Nevus Syndrome.

Arivarasan Karunamurthy Information

University

Position

University of Pittsburgh Medical Center

Citations(all)

1384

Citations(since 2020)

1085

Cited By

703

hIndex(all)

15

hIndex(since 2020)

13

i10Index(all)

21

i10Index(since 2020)

16

Email

University Profile Page

Google Scholar

Arivarasan Karunamurthy Skills & Research Interests

Dermatopathology

Molecular Genetic Pathology

Immunotherapeutics

Cancer Genomics

Top articles of Arivarasan Karunamurthy

Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy

The Oncologist

2024/4/24

45 An integrative immune signature of complementary circulating and tumoral biomarkers maximizes the predictive power of adjuvant immunotherapeutic benefits for high-risk melanoma

2023/11/1

3D reconstruction of skin and spatial mapping of immune cell density, vascular distance and effects of sun exposure and aging

Communications Biology

2023/7/19

Hydroxychloroquine‐induced repetitive atypical pustular drug eruptions in the same patient separated by 12 years

Clinical Case Reports

2023/7

Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes

Frontiers in Immunology

2023/6/22

An integrated immune signature predictive of adjuvant immunotherapeutic benefits for high-risk melanoma

Cancer Research

2023/4/4

Poorer survival outcomes in patients with multiple versus single primary melanoma

Cancer

2022/6/1

Improvement of Unilateral Breast Hypoplasia With Oral Spironolactone in a Patient With Becker Nevus Syndrome.

Journal of drugs in dermatology: JDD

2022/4/1

Li Wei Chang
Li Wei Chang

H-Index: 3

Arivarasan Karunamurthy
Arivarasan Karunamurthy

H-Index: 11

Human digital twin: automated cell type distance computation and 3D atlas construction in multiplexed skin biopsies

bioRxiv

2022/3/30

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Journal for immunotherapy of cancer

2022

Cutaneous metastasis of primary diffuse large B‐cell lymphoma of the central nervous system developing 4 years after complete remission: Diagnosis confirmed by comparison of clones

Journal of cutaneous pathology

2022/1

Arivarasan Karunamurthy
Arivarasan Karunamurthy

H-Index: 11

Random Skin Biopsy Is a Useful Procedure in the Evaluation of Hemophagocytic Lymphohistiocytosis: A Case Report and Review of Literature

2022/12/1

Arivarasan Karunamurthy
Arivarasan Karunamurthy

H-Index: 11

1000 Melanoma lymph node metastases are associated with hypoxia and immunologic dysfunction

2022/11/1

Arivarasan Karunamurthy
Arivarasan Karunamurthy

H-Index: 11

Diwakar Davar
Diwakar Davar

H-Index: 17

605 Neoadjuvant vidutolimod (vidu) and nivolumab (nivo) results in MPR and immune activation in high-risk resectable melanoma (MEL): final phase II clinical trial results

2022/11/1

Deep penetrating nevus with clear‐cell changes.

Journal of Cutaneous Pathology

2022/11/1

Arivarasan Karunamurthy
Arivarasan Karunamurthy

H-Index: 11

Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma

Cancers

2022/10/11

Phialophora infection mimics pyogenic granuloma in a patient with a renal transplant

JAAD Case Reports

2022/10/1

Arivarasan Karunamurthy
Arivarasan Karunamurthy

H-Index: 11

Intractable pruritic dermatosis of the perineum in a woman with highly unusual pathologic features

JAAD Case Reports

2022/9/1

Arivarasan Karunamurthy
Arivarasan Karunamurthy

H-Index: 11

Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared …

Journal of translational medicine

2022/6/3

See List of Professors in Arivarasan Karunamurthy University(University of Pittsburgh)

Co-Authors

academic-engine